| Dec-14-19 06:59PM | Hedge Funds Have Never Been More Bullish On Agile Therapeutics Inc (AGRX) Insider Monkey |
| Nov-15-19 10:09AM | The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval Benzinga -37.39% |
| Nov-14-19 04:30PM | Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period GlobeNewswire +10.19% |
| Nov-11-19 04:40PM | RBC: 3 Stock Picks Set to Soar 30%+ TipRanks |
| Nov-05-19 06:53AM | The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment Benzinga +34.83% |
| Nov-04-19 11:24AM | Agile (AGRX) Stock Surges Over 370%, Whats Next? TipRanks +31.85% |
| Oct-31-19 01:11PM | Agile Therapeutics' stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nod MarketWatch +223.80% |
| 10:52AM | Agile Therapeutics Rallies After FDA Panel Backs Contraceptive Patch Benzinga |
| 08:34AM | Benzinga Pro's Top 5 Stocks To Watch For Thurs., Oct. 31, 2019: AAPL, FB, AGRX, X, CROX Benzinga |
| Oct-30-19 06:33PM | Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15) GlobeNewswire |
| Oct-29-19 05:24PM | Agile (AGRX): Should You Catch this Falling Knife? TipRanks -17.92% |
| 07:32AM | The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study Benzinga |
| Oct-28-19 08:00AM | Agile Therapeutics Reports Third Quarter 2019 Financial Results GlobeNewswire -59.32% |
| Oct-25-19 09:30AM | Is Agile Therapeutics (AGRX) Outperforming Other Medical Stocks This Year? Zacks |
| 09:00AM | Agile Therapeutics (AGRX) Upgraded to Buy: Here's What You Should Know Zacks |
| Oct-24-19 03:57PM | 5 'Strong Buy' Biotech Stocks With Rapidly Approaching Catalysts Kiplinger |
| Oct-14-19 12:17AM | 3 Top Biotech Stocks With Major Catalysts in October TipRanks |
| Oct-01-19 09:44AM | The Zacks Analyst Blog Highlights: Barrett Business Services, Hibbett Sports, Construction Partners, Agile Therapeutics and Boot Barn Zacks |
| Sep-30-19 11:16PM | Penny Stocks to Buy Using Technical Analysis for October 2019 Investopedia +5.80% |
| 08:05AM | Trade Worries Resurface! Buy These 5 U.S. Stocks Now Zacks |
| Sep-25-19 08:23AM | Top Ranked Momentum Stocks to Buy for September 25th Zacks -5.45% |
| Sep-19-19 10:29AM | Zynerba Releases Data on Epilepsy Candidate, Stock Down Zacks -8.53% |
| Sep-10-19 09:00AM | Agile Therapeutics (AGRX) Upgraded to Strong Buy: Here's What You Should Know Zacks |
| Sep-06-19 07:30AM | Agile Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire +9.60% |
| Sep-05-19 10:12AM | 3 Strong Buy Biotech Stocks Ahead of FDA Verdicts SmarterAnalyst +9.65% |
| Aug-30-19 09:45AM | Agile (AGRX) Stock Could Be Ready to Break Out TipRanks |
| Aug-22-19 10:50AM | New Strong Buy Stocks for August 22nd Zacks |
| Aug-08-19 04:15PM | Agile Therapeutics Announces Full Exercise of Over-Allotment Option by Underwriters GlobeNewswire |
| Aug-02-19 09:05AM | Agile Therapeutics Announces Pricing of $12 Million Underwritten Public Offering of Common Stock GlobeNewswire -9.55% |
| Aug-01-19 04:01PM | Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire -5.17% |
| 08:00AM | Agile Therapeutics Reports Second Quarter 2019 Financial Results GlobeNewswire |
| Jul-18-19 07:30AM | Agile Therapeutics Appoints Chief Financial Officer GlobeNewswire |
| Jun-24-19 04:15PM | Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla® (AG200-15) GlobeNewswire |
| May-22-19 07:00AM | Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® GlobeNewswire |
| May-17-19 07:30AM | Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla® GlobeNewswire |
| May-09-19 08:00AM | Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference GlobeNewswire |
| May-03-19 08:00AM | Agile Therapeutics to Present Combined Safety Data from Three Phase 3 Studies at the 2019 ACOG Annual Meeting GlobeNewswire |
| May-02-19 06:56PM | Agile Therapeutics: 1Q Earnings Snapshot Associated Press |
| 04:15PM | Agile Therapeutics Reports First Quarter 2019 Financial Results GlobeNewswire |
| Mar-28-19 08:00AM | Agile Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference in London, UK GlobeNewswire |
| Mar-15-19 08:00AM | Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress GlobeNewswire |
| Mar-14-19 12:00PM | AGRX: Numerous Catalysts in 2019 Zacks Small Cap Research |
| Mar-12-19 05:52PM | Agile Therapeutics: 4Q Earnings Snapshot Associated Press +15.97% |
| 04:15PM | Agile Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire |
| Mar-11-19 08:00AM | Agile Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire +26.32% |
| Mar-04-19 07:30AM | Agile Therapeutics Announces $7.8 Million Private Placement GlobeNewswire +19.70% |
| Feb-12-19 10:30AM | AGRX: Positive Results for Twirla® Adhesion Study; NDA Resubmission in 2Q19 Zacks Small Cap Research +9.37% |
| Feb-11-19 07:30AM | Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane® GlobeNewswire |
| Feb-07-19 08:00AM | Agile Therapeutics to Present at the 2019 BIO CEO and Investor Conference GlobeNewswire |
| Jan-11-19 10:45AM | AGRX: Twirla® Adhesion Study Underway; NDA Resubmission in 2Q19 Zacks Small Cap Research |
| 08:38AM | The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA Benzinga |
| Jan-10-19 04:15PM | Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance GlobeNewswire |
| Dec-27-18 07:25AM | Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire |
| Dec-18-18 08:00AM | Agile Therapeutics to Present at Biotech Showcase 2019 GlobeNewswire -10.77% |
| Dec-13-18 04:15PM | Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane® GlobeNewswire |
| Nov-13-18 01:32PM | Agile Therapeutics Inc (NASDAQ:AGRX): Are Analysts Optimistic? Simply Wall St. |
| Nov-05-18 01:30PM | AGRX: Awaiting Details of Adhesion Study for Twirla® Zacks Small Cap Research |
| Nov-02-18 05:12AM | Agile Therapeutics: 3Q Earnings Snapshot Associated Press +13.82% |
| Nov-01-18 04:15PM | Agile Therapeutics Reports Third Quarter 2018 Financial Results GlobeNewswire +9.72% |
| Oct-24-18 08:00AM | Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP) GlobeNewswire |
| Oct-23-18 08:25AM | New Research Coverage Highlights MEDIFAST INC, Palo Alto Networks, Salesforce, Agile Therapeutics, Dicerna Pharmaceuticals, and Corbus Pharmaceuticals Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire |
| Oct-22-18 08:15AM | Agile Therapeutics Gets a Path Forward for Twirla, Analysts Review and Target ACCESSWIRE -15.20% |
| Oct-16-18 08:00AM | Todays Research Reports on Stocks to Watch: Auris Medical Holding and Agile Therapeutics ACCESSWIRE |
| Oct-10-18 11:15AM | AGRX: FDA Provides Path to NDA Resubmission for Twirla® Zacks Small Cap Research -7.63% |
| 08:00AM | Today's Research Reports on Trending Tickers: Agile Therapeutics and Horizon Pharma ACCESSWIRE |
| Oct-09-18 08:00AM | Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA GlobeNewswire +53.71% |
| Sep-14-18 10:04AM | Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market? Simply Wall St. -25.36% |
| Sep-12-18 08:00AM | Todays Research Reports on Stocks to Watch: Agile Therapeutics and BioPharmX ACCESSWIRE -17.91% |
| Sep-11-18 10:35AM | New Growth Opportunities Jump for 3 Biotech Stocks in 2018 ACCESSWIRE +116.83% |
| Aug-29-18 08:10AM | Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Aug-09-18 09:45AM | AGRX: Formal Dispute Resolution Continues to Office of New Drugs Zacks Small Cap Research -5.32% |
| Aug-03-18 08:11AM | Agile Therapeutics: 2Q Earnings Snapshot Associated Press +8.58% |
| 08:00AM | Agile Therapeutics Reports Second Quarter 2018 Financial Results GlobeNewswire |
| Jul-31-18 07:10AM | Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks ACCESSWIRE |
| Jul-24-18 04:10PM | FDAs Office of Drug Evaluation III Denies Agile Therapeutics, Inc.s Initial Formal Dispute Resolution Request GlobeNewswire |
| Jun-25-18 07:10AM | Free Technical Research on Akorn and Three More Generic Drugs Equities ACCESSWIRE |
| Jun-08-18 02:10PM | AGRX: Files Formal Dispute Resolution with the FDA Zacks Small Cap Research |
| 09:20AM | Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs Benzinga |
| Jun-07-18 04:10PM | Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance GlobeNewswire |
| May-22-18 09:25AM | AGRX: Determining a Path Forward Following Receipt of Meeting Minutes Zacks Small Cap Research |
| May-21-18 08:00AM | Todays Research Reports on Stocks to Watch: Agile Therapeutics and Arrowhead Pharmaceuticals ACCESSWIRE |
| May-18-18 10:44AM | Agile Therapeutics sinks after FDA feedback on contraceptive Reuters -72.40% |
| 08:10AM | Consolidated Research: 2018 Summary Expectations for Verint, Mesabi Trust, Clearwater Paper, Agile Therapeutics, Community Trust, and Layne Christensen Fundamental Analysis, Key Performance Indications GlobeNewswire |
| 07:51AM | Agile Therapeutics exploring funding options after FDA meeting Reuters |
| 07:30AM | Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy GlobeNewswire |
| May-15-18 01:51PM | Corium International (CORI) Q2 2018 Earnings Conference Call Transcript Motley Fool |
| May-14-18 11:55AM | AGRX: Waiting on Meeting Minutes from FDA; Planning for 2Q18 Twirla® NDA Resubmission Zacks Small Cap Research |
| May-11-18 06:51PM | Have Investors Priced In Agile Therapeutics Incs (NASDAQ:AGRX) Growth? Simply Wall St. |
| May-07-18 04:38PM | Agile Therapeutics: 1Q Earnings Snapshot Associated Press +6.62% |
| 04:10PM | Agile Therapeutics Reports First Quarter 2018 Financial Results GlobeNewswire |
| May-02-18 08:58PM | When Can We Expect A Profit From Agile Therapeutics Inc (NASDAQ:AGRX)? Simply Wall St. |
| Mar-30-18 08:00AM | [$$] 3 Biotech Stocks a Pro Is Buying Now Barrons.com |
| Mar-28-18 03:28PM | What Should Investors Know About Agile Therapeutics Incs (NASDAQ:AGRX) Long Term Outlook? Simply Wall St. -9.36% |
| Mar-23-18 07:30AM | New Research: Key Drivers of Growth for At Home Group, Griffon, Mitek, J & J Snack Foods, Lindsay, and Agile Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Mar-20-18 12:30PM | Is Agile Therapeutics Incs (NASDAQ:AGRX) Balance Sheet A Threat To Its Future? Simply Wall St. |
| Mar-14-18 07:45AM | Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition GlobeNewswire |
| Mar-12-18 05:25PM | Agile Therapeutics reports 4Q loss Associated Press |
| 04:15PM | Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire |
| Jan-24-18 07:40AM | New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire |
| Dec-27-17 11:19AM | Analyst Remains Confident In Corium Despite Partner's Bad FDA News Benzinga |
